Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2025-12-25 @ 5:01 PM
NCT ID: NCT01059903
Description: Adverse Events (AEs) refer to the Safety Set (SS). The SS includes all randomized subjects who received at least 1 dose of study medication.
Frequency Threshold: 0
Time Frame: Adverse Events were collected up to 14 days after the last patch removal.
Study: NCT01059903
Study Brief: Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Rotigotine PR2.2.1 Rotigotine transdermal patch 4.5 mg/10 cm\^2, test drug product PR2.2.1 ; single application of 1 patch for 24 hours None None 0 49 23 49 View
Rotigotine PR2.1.1 Rotigotine transdermal patch 4.5 mg/10 cm\^2, reference drug product PR2.1.1 ; single application of 1 patch for 24 hours None None 0 49 26 49 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Dyspepsia NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Gingival Bleeding NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Fatigue NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (9.1) View
Thirst NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (9.1) View
Lipase Increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (9.1) View
Blood Amylase Increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (9.1) View
Blood Creatine Phosphokinase Increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (9.1) View
Alanine Aminotransferase Increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (9.1) View
Blood Bilirubin Increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (9.1) View
Anorexia NON_SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (9.1) View
Pain in Jaw NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (9.1) View
Back Pain NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (9.1) View
Proteinuria NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (9.1) View
Pharyngolaryngeal Pain NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (9.1) View
Rhinorrhoea NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (9.1) View
Flushing NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (9.1) View
Hot Flush NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (9.1) View
Orthostatic Hypotension NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (9.1) View
Herpes Simplex NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (9.1) View
Rhinitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (9.1) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View
Dizziness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View
Dizziness Postural NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View
Insomnia NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (9.1) View
Hyperhidrosis NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (9.1) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Vomiting NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Constipation NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Abdominal Pain NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (9.1) View
Application Site Pruritus NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (9.1) View
Application Site Oedema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (9.1) View
Application Site Paraesthesia NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (9.1) View
Somnolence NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (9.1) View